Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other Psychoactive Substance Dependence with Withdrawal
- ICD-10 Code: F19.23
Summary
Other psychoactive substance dependence with withdrawal refers to a pattern of substance use that leads to clinically significant impairment, characterized by a strong desire to use the substance, difficulty controlling use, and continued use despite negative consequences, accompanied by withdrawal symptoms when use is reduced or stopped. This condition involves substances not classified under more specific categories (e.g., alcohol, opioids, cannabis) and may include dependence on agents like caffeine, nicotine, or other non-specified psychoactive substances.
Causes
The causes of this condition can include chronic use of psychoactive substances that alter brain function, psychological factors such as stress or trauma, and social influences like peer pressure. The addictive potential of these substances, combined with repeated use, can lead to dependence over time, resulting in withdrawal symptoms when use is discontinued.
Risk Factors
- Genetic predisposition to addiction
- Co-occurring mental health disorders (e.g., anxiety, depression)
- Early exposure to psychoactive substances
- Environmental factors (e.g., access to substances, social norms)
Symptoms
- Intense cravings or urges to use the substance
- Inability to reduce or control use despite efforts
- Withdrawal symptoms when not using (e.g., irritability, fatigue, nausea)
- Neglect of personal, occupational, or social responsibilities
Diagnosis
Diagnosis typically involves a thorough medical and psychological evaluation, including patient self-reports of substance use patterns, assessment of withdrawal symptoms, and use of standardized questionnaires or clinical criteria to confirm dependence and withdrawal.
Treatment Options
Treatment may include detoxification to manage withdrawal symptoms, behavioral therapies to address underlying causes, and support groups or medications to reduce cravings and prevent relapse. Individualized plans are often necessary based on the substance involved and patient needs.
Prognosis and Follow-Up
Prognosis varies depending on the severity of dependence, presence of co-occurring disorders, and adherence to treatment. Regular follow-up is important to monitor progress, adjust treatment, and address potential relapse.
Complications
Complications may include severe withdrawal reactions, relapse, co-occurring mental health disorders, and negative impacts on physical health, relationships, or employment.
Lifestyle & Prevention
Lifestyle modifications such as avoiding triggers, building a support network, and engaging in healthy activities can help prevent relapse. Prevention strategies include education about substance risks and early intervention for at-risk individuals.
When to Seek Professional Help
Seek professional help if withdrawal symptoms are severe, substance use is uncontrollable, or negative consequences (e.g., health, social, or occupational) are evident. Immediate care is needed for severe withdrawal or overdose.
Tips for Medical Coders
Document the presence of withdrawal symptoms and the specific psychoactive substance involved. Ensure clinical notes support the diagnosis and specify if withdrawal is a key feature. Code F19.23 is appropriate when dependence and withdrawal are both present.
F19.23 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.